clinical experience with procarbazine in
โ
David C. Stolinsky; Joel Solomon; Reginald P. Pugh; Alex R. Stevens; Edwin M. Ja
๐
Article
๐
1970
๐
John Wiley and Sons
๐
English
โ 555 KB
Seventy-two patients with Hodgkin's disease, reticulum cell sarcoma, lymphosarcoma, and various other malignant neoplasms were treated with the methylhydrazine derivative procarbazine hydrochloride (Matulane,@ NSC-77213). Response to therapy could be evaluated in 50 patients. Favorable responses occ